Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts

K Irani1, Y Xia, J L Zweier

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Science (New York, N.Y.)
|March 14, 1997
PubMed

Insights

Constitutively active H-RasV12 transforms cells, increasing reactive oxygen species (ROS) like superoxide. Antioxidants and inhibitors targeting Ras pathways, flavoproteins, and Rac1 suppressed ROS and cell growth, suggesting ROS mediation in Ras-induced transformation.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Ras proteins are key regulators of cell signaling pathways.
  • Aberrant Ras signaling is implicated in various cancers.
  • Reactive oxygen species (ROS) play complex roles in cell proliferation and transformation.

Purpose of the Study:

  • To investigate the role of reactive oxygen species (ROS) in H-RasV12-induced fibroblast transformation.
  • To identify the signaling pathways involved in ROS production downstream of H-RasV12.
  • To explore the potential of targeting ROS pathways as a therapeutic strategy against Ras-driven cancers.

Main Methods:

  • NIH 3T3 fibroblasts were stably transformed with H-RasV12.
  • Superoxide (.O2-) production was measured.
  • Dominant-negative Ras and Rac1 isoforms were expressed.
  • Cells were treated with farnesyltransferase inhibitor and diphenylene iodonium.
  • Mitogenic activity was assessed after N-acetyl-L-cysteine treatment.
  • Mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) activities were analyzed.

Main Results:

  • H-RasV12-transformed cells exhibited significantly increased superoxide (.O2-) production.
  • .O2- production was reduced by dominant-negative Ras/Rac1, farnesyltransferase inhibitor, and diphenylene iodonium.
  • Antioxidant treatment (N-acetyl-L-cysteine) inhibited the mitogenic activity of H-RasV12 cells.
  • MAPK activity was decreased, and JNK was not activated in H-RasV12-transformed cells.

Conclusions:

  • H-RasV12-induced cell transformation is associated with increased ROS production, specifically superoxide (.O2-).
  • Rac1 and flavoprotein-dependent pathways are involved in H-RasV12-mediated ROS generation.
  • Ras-induced cell cycle progression may be mediated by ROS independently of MAPK and JNK pathways, suggesting a novel therapeutic target for Ras-driven cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...